Fairvalue-Calculator Fairvalue-Calculator
EN DE

PTX Metals Inc (PTX) Fair Value & Analysis

Healthcare · CA · Market cap A$76.8M

PriceA$0.0600
Fair ValueA$0.0500
Upside-16.7%
Quality95/100
Evidence: Low Range A$0.0400 – A$0.0600

Analysis

PTX Metals Inc (PTX) currently trades at A$0.0600, while our model-based Fair Value estimate is A$0.0500 — implying the stock looks roughly 16.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

PTX Metals Inc., together with its subsidiaries, explores for and evaluates mineral properties in Canada. The company explores for copper, gold, nickel, platinum group element, and cobalt deposits. Its flagship projects include the 100%-owned W2 copper-nickel-PGE project, which consists of 353 mining claims covering an area of 21,306 hectares, as well as an option to earn a 100% interest in an additional 52 claims covering an area of 1,456 hectares located in the Ring of Fire region, Ontario; the 75%-owned Shining Tree gold project, which consists of 1,115 claims covering an area of 23,385 hectares located in the Churchill, MacMurchy, and Asquith Townships in Ontario; the 75%-owned Heenan gold project, which consists of 26 claims covering an area of 425 hectares located in the Heenan and Benton Townships, northwest of Sudbury, Ontario; and the 75%-owned Mallard gold project, which consists of 270 claims covering an area of 5,275 hectares located in the Mallard Township, northwest of…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -63%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.